By the Abstracts – MSK Authors at the 2015 ASCO Meeting

The American Society of Clinical Oncology meeting this year had close to 6,000 abstracts submitted for review, with 4,882 abstracts published in conjunction with this conference. Of these abstracts 2,392 were presented onsite during the poster discussion, oral abstract, and poster sessions. Details can be found on the ASCO website.

Memorial Sloan Kettering contributed 296 abstracts which represents an increase of approximately 15% from last year’s total abstract count. Also last year, there were 7 MSK authors that published 10 or more abstracts. This year there were 12 MSK authors that published 10 or more abstracts: C.A. Hudis (18), M.F. Berger (15), D.M. Hyman (15), M.G. Kris (15), R.J. Motzer (13), M.E. Arcila (12), L.B. Saltz (11), M. Ladanyi (10), H.I. Scher (10), D.B. Solit (10), M.H. Voss (10), and J.D. Wolchok (10). The top three categories (as determined by ASCO) were Genitourinary (Nonprostate) Cancer (26), Gastrointestinal (Noncolorectal) Cancer (21), and Lung Cancer-Non-Small Cell Metastatic (21). The abstracts include three on the historic IBM Watson Oncology application being implemented at MSK.

Please click to download the list of MSK abstracts as a PDF File or an EndNote Library. The PDF File contains the citation and URL for each abstract. Contact us if you have any questions or need support with the EndNote Library.

The Latest in Cancer Research

Here are a few highlights of cancer research news that have recently caught my attention:

  • A recent study conducted by Perelman School of Medicine at the University of Pennsylvania found that nearly 10 percent of US women live too far from access to gynecologic cancer care. More on this study published in Gynecologic Oncology.
  • Researchers at the Annual Meetings of Nuclear Medicine and Molecular Imaging demonstrated how a new molecular imaging agent detects prostate cancer that has spread to other tissue. A total of 28 subjects were imaged for this study. For more, read public release.
  • Scientists at the Washington University in St Louis found a way to disrupt brain tumor cells. While brain cancer is still very difficult to treat, this new discovery may help attack the essence of some of these deadly tumors. The findings were published in Cell Reports.

Continue reading

New Innovations in Cancer Research

Here are a few highlights of cancer research news that have recently caught my attention:

  • In a head-to-head clinical trial comparing standard chemotherapy with the immunotherapy drug nivolumab, researchers at Johns Hopkins found that on average patients treated with nivolumab lived 3.2 months longer than those receiving chemotherapy. Results of the trial have been published in NEJM.
  • The European Society for Medical Oncology (ESMO) recently announced the publication of the ESMO Magnitude of Clinical Benefits Scale, a tool to assist oncologists in assessing effective cancer medicines for their patients. Read more about this tool in Annals of Oncology. Continue reading